
Ustekinumab-aekn Now Interchangeable With Reference for PsA, PsO, CD, UC
Ustekinumab-aekn (Selarsdi) has received the interchangeable designation with the reference biologic ustekinumab (Stelara), as of April 30, 2025, for treating adults and pediatric with psoriatic arthritis, plaque psoriasis, Crohn disease, and ulcerative …